Aim and Objective:
To assess the relationship between serum folate and schizophrenia (SZ) risk in Chinese Han adult population in different papers, the systematic review and meta-analysis was conducted.
Materials and Methods:
We searched for this meta-analysis on three English databases (PubMed, Embase, and Web of science) and four Chinese databases (CNKI, SinoMed, Wanfang, and CQVIP) in March 27, 2021. Inclusion criteria: studies provided folate levels in serum of cases and controls as mean and standard deviation. Exclusion criteria: subjects were not Chinese Han adult population. The Newcastle-Ottawa Scale score was done to assess risk of bias in the included studies. Standard mean difference was used to measure the difference between SZ patients and healthy controls. Subgroup analyses by measurement time, duration, and age were performed, respectively.
Results:
This meta-analysis was included 19 publications involving 1571 SZ cases and 1283 healthy controls. In total studies, the pooled result showed that SZ patients had the decreased serum folate levels compared with healthy controls (SMD [95%CI] = -1.37[-1.83,-0.90], PSMD<0.001), and most of the subgroups, the associations were also reached decreased significant; while in the subgroup of drug using, the association was not reached significantly.
Conclusion:
Dose-response analysis and subgroup analyses by gender were not performed for the lack of the data. Folate deficiency is associated with the patients, and antipsychotic drugs might have positive effects on improving serum folate levels in Chinese Han adult SZ.